icodextrin and Hyperlipidemias

icodextrin has been researched along with Hyperlipidemias* in 2 studies

Reviews

2 review(s) available for icodextrin and Hyperlipidemias

Article	Year
[Continuous dialysis therapy for patients with diabetic nephropathy]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6 Topics: Arteriosclerosis Obliterans; Coronary Artery Bypass; Diabetic Nephropathies; Glucans; Glucose; Glycolipids; Humans; Hyperlipidemias; Icodextrin; Male; Middle Aged; Myocardial Infarction; Peritoneal Dialysis, Continuous Ambulatory; Prognosis; Renal Dialysis	2004
Management of high peritoneal transporters. Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2000, Volume: 20 Suppl 2 High transporters on chronic peritoneal dialysis are challenged by increased protein losses, high glucose absorption with associated metabolic abnormalities, and poor ultrafiltration. Furthermore, the relative risk of mortality and technique failure is higher in high transporters than in patients of other transport types. An approach for satisfactory management of such patients on peritoneal dialysis (PD) has not been clearly demonstrated. Topics: Animals; Arteriosclerosis; Biological Transport; Blood Pressure; Dialysis Solutions; Glucans; Glucose; Humans; Hyperlipidemias; Icodextrin; Peritoneal Dialysis; Peritoneum; Proteins; Serum Albumin; Treatment Failure; Ultrafiltration	2000

Article

Year

[Continuous dialysis therapy for patients with diabetic nephropathy].

Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6

Topics: Arteriosclerosis Obliterans; Coronary Artery Bypass; Diabetic Nephropathies; Glucans; Glucose; Glycolipids; Humans; Hyperlipidemias; Icodextrin; Male; Middle Aged; Myocardial Infarction; Peritoneal Dialysis, Continuous Ambulatory; Prognosis; Renal Dialysis

2004

Management of high peritoneal transporters.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2000, Volume: 20 Suppl 2

High transporters on chronic peritoneal dialysis are challenged by increased protein losses, high glucose absorption with associated metabolic abnormalities, and poor ultrafiltration. Furthermore, the relative risk of mortality and technique failure is higher in high transporters than in patients of other transport types. An approach for satisfactory management of such patients on peritoneal dialysis (PD) has not been clearly demonstrated.

Topics: Animals; Arteriosclerosis; Biological Transport; Blood Pressure; Dialysis Solutions; Glucans; Glucose; Humans; Hyperlipidemias; Icodextrin; Peritoneal Dialysis; Peritoneum; Proteins; Serum Albumin; Treatment Failure; Ultrafiltration

2000